IMPROVING METABOLIC CONTROL IN OBESE PATIENTS WITH TYPE 2 DIABETES MELLITUS

Abstract

Type 2 diabetes mellitus is one of the most common chronic metabolic disorders worldwide and is frequently associated with obesity, which significantly complicates disease management and worsens prognosis. Excess body weight contributes to insulin resistance, dyslipidemia, arterial hypertension, and chronic low grade inflammation, all of which impair metabolic control. Improving metabolic control in obese patients with type 2 diabetes is therefore a key objective of modern clinical practice. This article analyzes the pathophysiological relationship between obesity and type 2 diabetes, evaluates current approaches to metabolic control, and discusses integrated strategies including lifestyle modification, pharmacological therapy, and patient education. Particular attention is paid to individualized treatment plans and multidisciplinary management aimed at achieving sustainable glycemic control and reducing cardiovascular risk. The findings highlight that comprehensive and patient centered approaches can significantly improve metabolic outcomes and quality of life in obese individuals with type 2 diabetes [1,2].